These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2255397)

  • 21. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.
    McKenna DJ; Guan XM; Shulgin AT
    Pharmacol Biochem Behav; 1991 Mar; 38(3):505-12. PubMed ID: 1829838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ; Robinson SE; Rosecrans JA
    Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    Eur J Pharmacol; 1987 Feb; 134(2):245-8. PubMed ID: 2883012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization.
    Cudennec A; Duverger D; Lloyd KG; MacKenzie ET; McCulloch J; Motohashi N; Nishikawa T; Scatton B
    Brain Res; 1987 Oct; 423(1-2):162-72. PubMed ID: 2823984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in neurotransmitter receptors and glucose use after unilateral orbital enucleation.
    Chalmers DT; McCulloch J
    Brain Res; 1991 Feb; 540(1-2):243-54. PubMed ID: 1675915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
    Hekmatpanah CR; Peroutka SJ
    Eur J Pharmacol; 1990 Feb; 177(1-2):95-8. PubMed ID: 1971219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.
    Winslow JT; Insel TR
    J Pharmacol Exp Ther; 1990 Jul; 254(1):212-20. PubMed ID: 1973197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brain.
    Jonsson G; Gorio A; Hallman H; Janigro D; Kojima H; Zanoni R
    Brain Res; 1984 Nov; 318(2):171-80. PubMed ID: 6093923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of apomorphine upon local cerebral glucose utilization in conscious rats and in rats anesthetized with chloral hydrate.
    Grome JJ; McCulloch J
    J Neurochem; 1983 Feb; 40(2):569-76. PubMed ID: 6822839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered local cerebral glucose utilization by unilateral frontal cortical ablations in rats.
    Hosokawa S; Kato M; Aiko Y; Shima F
    Brain Res; 1985 Sep; 343(1):8-15. PubMed ID: 2864106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M; Hanson GR; Gibb JW
    Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central action of psychomotor stimulants on glucose utilization in extrapyramidal motor areas of the rat brain.
    London ED; Wilkerson G; Ori C; Kimes AS
    Brain Res; 1990 Mar; 512(1):155-8. PubMed ID: 1970943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
    Schmidt CJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):1-7. PubMed ID: 2433425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
    Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
    J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed effects of Soman: brain glucose use and pathology.
    Pazdernik TL; Cross R; Giesler M; Nelson S; Samson F; McDonough J
    Neurotoxicology; 1985; 6(3):61-70. PubMed ID: 4047516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orally administered MDMA causes a long-term depletion of serotonin in rat brain.
    Finnegan KT; Ricaurte GA; Ritchie LD; Irwin I; Peroutka SJ; Langston JW
    Brain Res; 1988 Apr; 447(1):141-4. PubMed ID: 2898273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats.
    Yeh SY; Hsu FL
    Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW; Stone DM; Stahl DC; Hanson GR
    NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in local cerebral blood flow in mature rats following prenatal exposure to cocaine.
    Kelly PA; Ritchie IM; Sharkey J; McBean DE
    Neuroscience; 1994 May; 60(1):183-9. PubMed ID: 8052411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.